If you have Polycythemia Vera and are experiencing complications, you may be eligible to participate in a research study testing the safety of a new drug called GIVinostat.

We are conducting a research study to evaluate sleep and psychological outcomes in individuals 1-month to 3-months post-ACLR. This will help identify changes after ACLR to help develop future interventions to improve outcomes after ACLR.

Do you spend a large portion of your day sitting? Do you exercise less than 90 minutes per week? If so, you may be able to take part in a study looking at how sitting and movement affect your life. We want to help lower the chances of getting heart disease and diabetes. Compensation provided.

Do you have recurring Chronic Lymphocytic Leukemia? If so, you may be able to take part in a study on two medicines to treat patients whose chronic lymphocytic leukemia has come back. We will also check if this treatment is safe for treatment.

Do you have thyroid cancer? If so, you may be eligible to participate in a research study to see which targeted therapy will work better to prolong the time until your tumor grows or spreads, after initial treatment.

Do you have mycobacterial lung infection (such as MAC or M. Abscessus)? Are you currently receiving treatment for this infection? If so, you may be able to take part in a study to see how well inhaled Clofazimine works to treat mycobacterial lung infections. By taking part, you can receive up to $4,100.

We're studying how young adults respond to sexual media, including their thoughts, experiences, and behaviors.

The purpose of this study is to explore how undergraduates use and think about generative AI. I will be conducting a focus group in order to hear directly from students about the ways that they use (or don't use) AI, how they evaluate AI-generated content, what they like about generative AI, and any concerns they have. By learning from students' perspectives, I will gain a better understanding of how to create AI instruction that meets students' needs and interests.

Join a Research Study for an Investigational MDS Treatment! Doctors are testing two study medicines for people with Myelodysplastic Syndromes (MDS) and an IDH1 mutation who haven't had certain treatments before.

If you have bronchiectasis and have needed antibiotics for worsening symptoms or flare-ups in the past year, you might be eligible to try a new inhaled medication called Ensifentrine. We want to see if this medication can help reduce symptoms and prevent flare-ups. You will be compensated for your participation.